Volume 67, Issue 5, Supplement , Pages 61-70, May 2009
The Pathogenesis of Bisphosphonate-Related Osteonecrosis of the Jaw: So Many Hypotheses, So Few Data
To access this article, please choose from the options below
Dr Allen has research contracts with The Alliance for Better Bone Health (Mason, OH), and Amgen (Thousand Oaks, CA). He also serves as a consultant for Procter and Gamble and Merck and Co. Dr Burr has research grants from The Alliance for Better Bone Health, Eli Lilly, and Amgen. He is a consultant and is on the speakers bureau for Eli Lilly and The Alliance for Better Bone Health. Dr Burr also has Material Transfer Agreements with Merck, Eli Lilly, and NephroGenex Inc.
PII: S0278-2391(09)00112-8
doi:10.1016/j.joms.2009.01.007
© 2009 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.
Volume 67, Issue 5, Supplement , Pages 61-70, May 2009
